DK
Insider
Daphne Karydas
DirectorDaphne Karydas (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $690K of MLYS (15,000 sh across 2 lots, as filed), executed Nov 13 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$690K
shares × price, as filed
Last traded
Nov 13 2025
Filed Nov 13 2025
Median ADV $38.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $690K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
MLYS
Mineralys Therapeutics, Inc.
MLYS · 0 buys · 1 sell
1 filing
Recent filings
MLYSSALE
Mineralys Therapeutics, Inc.
View filing →
$690K15,000 sh across 2 lots
Exec Nov 13 2025
Filed Nov 13 2025 · 5:30 PM ET